Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06405594 · ClinicalTrials.gov registry record · NA

Neurocognitive Mechanisms of Sentence Production Impairment in Aphasia

A NA study of Stroke and Healthy Aging, sponsored by University of Maryland, College Park.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT06405594 is a NA study of Stroke and Healthy Aging that is actively recruiting participants, run by University of Maryland, College Park. The registered enrollment target is 350 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06405594, a NA study of Stroke and Healthy Aging, is actively recruiting participants, sponsored by University of Maryland, College Park.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The proposed research is relevant to public health because stroke is a leading cause of long-term disability among older adults and communication impairments resulting from stroke have a significant negative impact on quality of life. By seeking to better understand post-stroke aphasia, this project lays the groundwork for development of new interventions, and aligns with NIDCD's priority areas 1 (understanding normal function), 2 (understanding diseases), and 3 (improving diagnosis, treatment, and prevention).

Interventions

  • BEHAVIORAL Language Condition

Study Locations (1)

Maryland

  • University of Maryland - College Park

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2024-08-01
Est. Completion 2029-06
Phase NA

What the Registry Record Tells You About NCT06405594

The ClinicalTrials.gov registry entry for NCT06405594 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Language Condition is the first listed.

NCT06405594 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06405594 about?

NCT06405594 is a clinical study titled "Neurocognitive Mechanisms of Sentence Production Impairment in Aphasia". The proposed research is relevant to public health because stroke is a leading cause of long-term disability among older adults and communication impairments resulting from stroke have a significant negative impact on quality of life. By seeking to better understand post-stroke aphasia, this project...

What is the current status of trial NCT06405594?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-08-01. Estimated completion is 2029-06.

What conditions does trial NCT06405594 study?

This clinical trial studies the following conditions: Stroke, Healthy Aging, Aphasia, Acquired.

What interventions are being tested in trial NCT06405594?

The interventions under investigation include: Language Condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT06405594?

This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06405594 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.